Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1463315

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1463315

Global FMD Disease Market Size, Share, Growth Analysis, By Technique(Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines, Oil-based Vaccines)), By Animal Type(Cattle, Sheep and goat) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global FMD disease market size was valued at USD 2.39 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 4.82 billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

The global adoption of veterinary vaccines, particularly those aimed at combating Foot-and-Mouth Disease (FMD), has experienced significant growth due to the increased demand for animal products and a larger population of animals. This surge can be attributed to the heightened prevalence of livestock and zoonotic diseases in recent years, influenced by factors such as environmental changes and rapid globalization. These factors have played a substantial role in driving the veterinary vaccine market, as governments worldwide prioritize safe medical practices for various animals, including communal and livestock species. Legislation addressing zoonotic pathogens is in effect in both developed and developing nations, recognizing the potential severe economic consequences of an outbreak on a nation's gross domestic product (GDP). Measures to mitigate these risks include culling infected animals and maintaining adequate vaccine stockpiles with updated strains. The dynamic growth observed in the animal sector, driven by increasing demand for products such as milk, chicken eggs, meat, and fabric, has attracted significant investment in advanced machinery and modern technologies. Preventive measures against FMD, such as vaccination, are deemed crucial interventions by governments and private stakeholders in the animal industry, given the substantial financial losses associated with disease outbreaks. The absence of a definitive cure underscores the importance of vaccination, particularly considering the various means through which infection can occur. In developing countries where livestock production significantly contributes to GDP, animal healthcare practices receive considerable attention. Government organizations in these nations prioritize the development of new medications and vaccination programs to safeguard cattle health. Conversely, regions with stringent measures and restrictions on animal movement, particularly in affluent areas like North America and Europe, have effectively minimized FMD outbreaks and thus have reduced reliance on FMD vaccines.

Top-down and bottom-up approaches were used to estimate and validate the size of the global FMD disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global FMD Disease Market Segmental Analysis

The global FMD disease market is segmented based on technique, animal type, and region. By technique, the market is segmented into conventional vaccines (aluminum hydroxide/saponin-based vaccines, oil-based vaccines), and emergency vaccines. By animal type, the market is segmented into cattle, sheep and goat, pigs, others (antelope, deer, bison, and camelids). By region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global FMD Disease Market

The increasing demand for animal protein and dairy products serves as a significant catalyst for the Foot-and-Mouth Disease (FMD) market, given the potential for substantial losses within the livestock industry caused by FMD outbreaks.

Restraints in the Global FMD Disease Market

The substantial expenses associated with FMD vaccines and diagnostic tests represent a significant barrier to the FMD market, especially in developing nations with extensive livestock populations.

Market Trends of the Global FMD Disease Market

A prominent market trend is the rising demand for Foot-and-Mouth Disease (FMD) vaccines, especially evident in developing nations. Governments worldwide are implementing initiatives to mitigate and prevent FMD outbreaks, thereby fueling the demand for FMD vaccines.

Product Code: SQMIG35E2021

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global FMD Disease Market by Technique

  • Market Overview
  • Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines
  • Oil-based Vaccines)
  • and Emergency Vaccines

Global FMD Disease Market by Animal Type

  • Market Overview
  • Cattle
  • Sheep and goat
  • Pigs
  • and Others (antelope
  • deer
  • bison
  • and camelids)

Global FMD Disease Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • MSD Animal Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indian Immunologicals Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biogenesis-Bago
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva SantA(C) Animale
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • China Animal Husbandry Co., Ltd. (CAH)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Guangdong Dahuanong Animal Health Products Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heska Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Indian Immunologicals Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lanzhou Veterinary Research Institute
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Limor de Colombia S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merial (Sanofi)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Minnesota Veterinary Diagnostic Laboratory
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PVT-Polish Veterinary Pharmaceuticals Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RAKARB Veterinary Biotech.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vecol S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VA(C)toquinol
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioveta a.s.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!